A carregar...
Prospect of rindopepimut in the treatment of glioblastoma
INTRODUCTION: Rindopepimut (CDX-110) is a peptide vaccine that targets epidermal growth factor receptor variant III (EGFRvIII), a tumor-specific epitope expressed in the most common and lethal primary malignant neoplasm of the brain – glioblastoma (GBM). AREAS COVERED: The EGFRvIII mutation introduc...
Na minha lista:
| Publicado no: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5787389/ https://ncbi.nlm.nih.gov/pubmed/28274144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1299705 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|